EUVIMEDEUVIMED entdecken
Crossref

Network pharmacology of berberine in the treatment of breast cancer

Yu-Tong Chen, Xiao Zhang

Integrate Medicine · 30.09.2024

DOI: 10.61958/imtd2483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 30.09.2024. Verfasst von Yu-Tong Chen und 1 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is one of the most prevalent malignant tumors affecting women globally, posing a significant public health challenge due to its high incidence and mortality rates. This study aims to elucidate the potential mechanisms of berberine in treating breast cancer using a network pharmacology approach.

Methods

We conducted a comprehensive literature search and database retrieval to identify keywords associated with berberine and breast cancer, followed by the collection of targets for both disease and berberine. Intersection analysis of these targets was performed using the Jvenn tool to identify common targets. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted on the intersecting targets using the Metascape database. The degree of enrichment and statistical significance were visually represented through various visualization tools such as STRING and Cytoscape software.

Results

We successfully identified retrieved datasets related to berberine and breast cancer, and corresponding targets. Using the Jvenn tool, we identified 279 common targets. We selected 15 KEGG pathways and 10 GO terms for further analysis based on ascending p-values. Additionally, a protein-protein interaction (PPI) network was constructed, revealing 10 core targets.

Conclusions

This study highlights the potential mechanisms of berberine in the treatment of breast cancer through a combination of network pharmacology and experimental validation, providing new insights and strategies for breast cancer therapy. Future research will focus on further elucidating the mechanisms of berberine and facilitating its translation from basic research to clinical application.

Zitieren

APA

Chen, Y., & Zhang, X. (2024). Network pharmacology of berberine in the treatment of breast cancer. Integrate Medicine. https://doi.org/10.61958/imtd2483

Vancouver

Chen Y, Zhang X. Network pharmacology of berberine in the treatment of breast cancer. Integrate Medicine. 2024. doi:10.61958/imtd2483

BibTeX
@article{Chen2024,
  author = {Chen, Yu-Tong and Zhang, Xiao},
  title = {Network pharmacology of berberine in the treatment of breast cancer},
  journal = {Integrate Medicine},
  year = {2024},
  doi = {10.61958/imtd2483}
}
Kostenlos starten →